Kuwayama H et al. |
Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:17439512
|
Wong WM et al. |
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15644048
|
Van Oijen AH et al. |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930892
|
Hurenkamp GJ et al. |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930901
|
Wheeldon TU et al. |
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12848630
|
Nseir W et al. |
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study. |
2012 |
Aliment. Pharmacol. Ther. |
pmid:22646167
|
Wong BC et al. |
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11380322
|
Meier R et al. |
Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11380323
|
Gisbert JP and Calvet X |
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. |
2012 |
Aliment. Pharmacol. Ther. |
pmid:22129228
|
Hokari K et al. |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11552922
|
Kamberoglou D et al. |
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11552924
|
Harb AH et al. |
Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for Helicobacter pylori eradication. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:26011564
|
al-Assi MT et al. |
Clarithromycin-amoxycillin therapy for Helicobacter pylori infection. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:7986970
|
Neri M et al. |
Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:7986974
|
Nada T et al. |
DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15298604
|
Lai KC et al. |
Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12641502
|
Zullo A et al. |
High eradication rates of Helicobacter pylori with a new sequential treatment. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12641522
|
de Francesco V et al. |
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16423002
|
Wong BC et al. |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651663
|
Fock KM et al. |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651664
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Katelaris PH et al. |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605864
|
Yousfi MM et al. |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605865
|
Choi IJ et al. |
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11856089
|
Bazzoli F et al. |
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11856090
|
Kim JS et al. |
Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860410
|
Malfertheiner P et al. |
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860399
|
Poon SK et al. |
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860412
|
Barth J and Hahne W |
Review article: rabeprazole-based therapy in Helicobacter pylori eradication. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11849125
|
Qasim A and O'Morain CA |
Review article: treatment of Helicobacter pylori infection and factors influencing eradication. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11849124
|
Sieg A et al. |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383519
|
Cestari R |
Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798804
|
Grimley CE et al. |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383520
|
Spadaccini A et al. |
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798805
|
Houben MH et al. |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383522
|
Bortolotti M et al. |
Effects of oral clarithromycin and amoxycillin on interdigestive gastrointestinal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798808
|
Veldhuyzen Van Zanten S et al. |
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121908
|
Isomoto H et al. |
5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121910
|
Canducci F et al. |
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121911
|
Kawabata H et al. |
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12534411
|
Gisbert JP et al. |
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012477
|
Catalano F et al. |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012478
|
Mason JM et al. |
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18793340
|
Fraser AG |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776748
|
Jung YS et al. |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776746
|
De Francesco V et al. |
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:14871280
|
Tankovic J et al. |
Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11328266
|
Koivisto TT et al. |
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15771764
|
Coelho LG et al. |
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12492742
|
Feydt-Schmidt A et al. |
Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12452940
|